http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103751764-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 |
| filingDate | 2013-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103751764-B |
| titleOfInvention | BAT3 albumen is preparing the application in the nervous system disease agent caused by Protein virus |
| abstract | The invention provides BAT3 albumen and prepare the application in the nervous system disease agent caused by Protein virus.The present invention also provides a kind of medicine being used for the treatment of the nervous system disease caused by Protein virus, especially for the medicine for the treatment of the nervous system disease caused by PrP106-126 toxic polypeptide, effective ingredient in described medicine is BAT3 albumen, is its aminoacid sequence as Seq? ID? shown in No.1, or this sequence is through replacing, lacking or add one or several amino acids formed aminoacid sequence with same function.The expression of BAT3 albumen alleviates the apoptosis that PrP106-126 toxic polypeptide causes neurocyte, providing effective and intensive research means for explaining the mechanisms of therapeutic action of this albumen to the neurone loss that Protein virus causes further, also having filled up the blank of this albumen in Therapeutic Method in addition. |
| priorityDate | 2013-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 53.